Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR3 | P46089 | 2/20 | 0.40 |
| ▸ | FAAH | O00519 | 1/20 | 0.35 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.35 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.35 |
| ▸ | ELANE | P08246 | 1/20 | 0.35 |
| ▸ | PRTN3 | P24158 | 1/20 | 0.35 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.35 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 6/20 | 0.33 |
| ▸ | ACHE | P22303 | 3/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 2/20 | 0.33 |
| ▸ | CES1 | P23141 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA5A | P35218 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3834477 | 0.86 | CA1 (0.38) | HPGDTSHRCA2CA1 | |
| SCHEMBL3725337 | 0.84 | HPGD (0.31) | HPGDTSHR | |
| Sulfuric Acid SCHEMBL6341005 | 0.84 | FAAH (0.31) | FAAHPRSS1PRSS2ELANEPRTN3 | |
| Trifluoromethanesulfonic Acid SCHEMBL3832689 | 0.81 | CA1 (0.40) | KCNH2ACHETSHRCA2CA1 | |
| Trifluoromethanesulfonic Acid SCHEMBL3835272 | 0.81 | KCNH2 (0.40) | KCNH2ACHECA2CA1CA5A | |
| Trifluoromethanesulfonic Acid SCHEMBL12499000 | 0.80 | LMNA (0.38) | GPR3ACHECA2CA1 | |
| SCHEMBL5974326 | 0.78 | CES2 (0.32) | FAAHPRSS1PRSS2ELANEPRTN3 | |
| Trifluoromethanesulfonic Acid SCHEMBL3096657 | 0.76 | MAPT (0.37) | GPR3PTPN1HPGDCA2CES1 | |
| Trifluoromethanesulfonic Acid SCHEMBL36383 | 0.75 | GPR3 (0.43) | GPR3PTPN1KCNH2ACHECA2 | |
| Trifluoromethanesulfonic Acid SCHEMBL36325 | 0.73 | GPR3 (0.42) | GPR3PTPN1KCNH2ACHECA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1187868-B1 | HYPERBRANCHED DENDRITIC POLYETHER AND PROCESS FOR MANUFACTURE THEREOF | PERSTORP AB (SE) | 2004-07-07 | — | — | EP | claimed |
| US-6617418-B1 | Thermally initiated cationic ring-opening polymerization of an oxetane having at least one reactive group in addition to the oxetane ether; end groups are hydroxyl | PERSTORP AB (SE) | 2003-09-09 | — | — | US | claimed |
| EP-1187868-A1 | HYPERBRANCHED DENDRITIC POLYETHER AND PROCESS FOR MANUFACTURE THEREOF | PERSTORP AB (SE) | 2002-03-20 | — | — | EP | claimed |
| WO-2000056802-A1 | HYPERBRANCHED DENDRITIC POLYETHER AND PROCESS FOR MANUFACTURE THEREOF | PERSTORP AB (SE) | 2000-09-28 | — | — | WO | claimed |
| US-9855267-B2 | Histone deacetylase inhibitors and compositions and methods of use thereof | CHDI FOUNDATION, INC. (US) | 2018-01-02 | — | — | US | disclosed |
| US-9765054-B2 | Histone deacetylase inhibitors and compositions and methods of use thereof | CHDI FOUNDATION, INC. (US) | 2017-09-19 | — | — | US | disclosed |
| US-20170042892-A1 | HISTONE DEACETYLASE INHIBITORS AND COMPOSITIONS AND METHODS OF USE THEREOF | CHDI FOUNDATION, INC. | 2017-02-16 | — | — | US | disclosed |
| US-9505736-B2 | Histone deacetylase inhibitors and compositions and methods of use thereof | CHDI FOUNDATION, INC. (US) | 2016-11-29 | — | — | US | disclosed |
| US-20150203468-A1 | HISTONE DEACETYLASE INHIBITORS AND COMPOSITIONS AND METHODS OF USE THEREOF | CHDI FOUNDATION, INC. | 2015-07-23 | — | — | US | disclosed |
| EP-2871955-A1 | HISTONE DEACETYLASE INHIBITORS AND COMPOSITIONS AND METHODS OF USE THEREOF | CHDI Foundation, Inc. (US) | 2015-05-20 | — | — | EP | disclosed |
| US-20140163009-A1 | HISTONE DEACETYLASE INHIBITORS AND COMPOSITIONS AND METHODS OF USE THEREOF | CHDI Foundation (US) | 2014-06-12 | — | — | US | disclosed |
| WO-2014014900-A1 | HISTONE DEACETYLASE INHIBITORS AND COMPOSITIONS AND METHODS OF USE THEREOF | CHDI FOUNDATION, INC. (US) | 2014-01-23 | — | — | WO | disclosed |
| EP-2432820-A2 | TERMINALLY UNSATURATED, OXETANE-BASED MACROMONOMERS, AND METHOD FOR THE PRODUCTION THEREOF | BYK-Chemie GmbH (DE) | 2012-03-28 | — | — | EP | disclosed |
| EP-2432819-A2 | POLYMERS OBTAINABLE FROM OXETANE BASED MACROMONOMERS, METHOD FOR THE PRODUCTION THEREOF, AND THE USE THEREOF AS ADDITIVES IN COATING AGENTS AND PLASTICS | BYK-Chemie GmbH (DE) | 2012-03-28 | — | — | EP | disclosed |
| WO-2010133289-A2 | TERMINALLY UNSATURATED, OXETANE-BASED MACROMONOMERS, AND METHOD FOR THE PRODUCTION THEREOF | BYK-CHEMIE GMBH (DE) | 2010-11-25 | — | — | WO | disclosed |
| WO-2010133288-A2 | POLYMERS OBTAINABLE FROM OXETANE BASED MACROMONOMERS, METHOD FOR THE PRODUCTION THEREOF, AND THE USE THEREOF AS ADDITIVES IN COATING AGENTS AND PLASTICS | BYK-CHEMIE GMBH (DE) | 2010-11-25 | — | — | WO | disclosed |
| EP-1187868-B1 | HYPERBRANCHED DENDRITIC POLYETHER AND PROCESS FOR MANUFACTURE THEREOF | PERSTORP AB (SE) | 2004-07-07 | — | — | EP | disclosed |
| US-6617418-B1 | Thermally initiated cationic ring-opening polymerization of an oxetane having at least one reactive group in addition to the oxetane ether; end groups are hydroxyl | PERSTORP AB (SE) | 2003-09-09 | — | — | US | disclosed |
| EP-1187868-A1 | HYPERBRANCHED DENDRITIC POLYETHER AND PROCESS FOR MANUFACTURE THEREOF | PERSTORP AB (SE) | 2002-03-20 | — | — | EP | disclosed |
| WO-2000056802-A1 | HYPERBRANCHED DENDRITIC POLYETHER AND PROCESS FOR MANUFACTURE THEREOF | PERSTORP AB (SE) | 2000-09-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140163009-A1 | HISTONE DEACETYLASE INHIBITORS AND COMPOSITIONS AND METHODS OF USE THEREOF | HDAC1, HDAC7, HDAC5 | GPR3 4833/4885FAAH 1389/4885PRSS1 863/4885 |
| US-20170042892-A1 | HISTONE DEACETYLASE INHIBITORS AND COMPOSITIONS AND METHODS OF USE THEREOF | HDAC1, HDAC7, HDAC5 | GPR3 4833/4885FAAH 1389/4885PRSS1 863/4885 |
| US-20150203468-A1 | HISTONE DEACETYLASE INHIBITORS AND COMPOSITIONS AND METHODS OF USE THEREOF | HDAC1, HDAC7, HDAC5 | GPR3 4833/4885FAAH 1389/4885PRSS1 863/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.